Cellibre Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Later Stage VC
- Investors
-
20
Cellibre General Information
Description
Operator of a cellular agriculture company intended to develop sustainable biological products. The company employs an organism-agnostic approach, precision fermentation, AI-driven enzyme and protein engineering, and high-throughput strain and bioprocess optimization, enabling pharmaceutical, functional health, beauty, and nutraceutical companies to access scalable, lower-cost, higher-quality ingredients while reducing reliance on agriculture and strengthening supply chain resilience.
Contact Information
Website
www.cellibre.comCorporate Office
- 10581 Roselle Street
- Suite 100
- San Diego, CA 92121-1519
- United States
Corporate Office
- 10581 Roselle Street
- Suite 100
- San Diego, CA 92121-1519
- United States
Cellibre Timeline
Cellibre Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 22-Oct-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 08-Oct-2024 | Completed | Generating Revenue | |||
| 4. Grant | 12-Jul-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 07-Sep-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 05-Oct-2020 | $8.4M | $8.4M | Completed | Generating Revenue | |
| 1. Debt - PPP | 01-May-2020 | $288K | Completed | Generating Revenue |
Cellibre Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2-1 | ||||||||
| Series A2 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 108,290 | $0.000010 | 8% | $29.41 | $29.41 | 1x | $29.41 | 3.82% |
| Series A | 326,502 | $0.000010 | 8% | $38.67 | $38.67 | 1x | $38.67 | 11.52% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cellibre Patents
Cellibre Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025160464-A1 | Engineered cells and methods for the synthesis of caffeoyltyramine and feruloyltyramine | Pending | 26-Jan-2024 | ||
| AU-2024308825-A1 | Enzymes and methods for the synthesis of bakuchiol and derivatives | Pending | 30-Jun-2023 | ||
| EP-4735589-A2 | Enzymes and methods for the synthesis of bakuchiol and derivatives | Pending | 30-Jun-2023 | ||
| WO-2025007156-A2 | Enzymes and methods for the synthesis of bakuchiol and derivatives | Inactive | 30-Jun-2023 | ||
| WO-2025007156-A3 | Enzymes and methods for the synthesis of bakuchiol and derivatives | Inactive | 30-Jun-2023 | C12N9/1085 |
Cellibre Signals
Cellibre Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dellin Investments | PE/Buyout | Minority | ||
| Symrise | Corporation | Minority | ||
| Verdant Ventures (Seattle) | Venture Capital | Minority | ||
| JourneyOne Ventures | Venture Capital | Minority | ||
| National Center For Complementary And Integrative Health | Government |
Cellibre FAQs
-
When was Cellibre founded?
Cellibre was founded in 2017.
-
Where is Cellibre headquartered?
Cellibre is headquartered in San Diego, CA.
-
What is the size of Cellibre?
Cellibre has 29 total employees.
-
What industry is Cellibre in?
Cellibre’s primary industry is Biotechnology.
-
Is Cellibre a private or public company?
Cellibre is a Private company.
-
What is Cellibre’s current revenue?
The current revenue for Cellibre is .
-
How much funding has Cellibre raised over time?
Cellibre has raised $30.1M.
-
Who are Cellibre’s investors?
Dellin Investments, Symrise, Verdant Ventures (Seattle), JourneyOne Ventures, and National Center For Complementary And Integrative Health are 5 of 20 investors who have invested in Cellibre.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process